Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Taiwan / NCT06834425
Active, not recruiting Not applicable

Efficacy of NSAID Peritendinous Injection for Acute Tendinitis

NCT06834425 · tracked via the Priya Life Science Taiwan tracker
Phase
Not applicable
Started
2025-02-10
Last updated
2025-02-19

Condition(s) studied

TendinitisAcute TendonitisNSAID (Non-Steroidal Anti-Inflammatory Drug)

Investigational drug(s) / intervention(s)

Peritendinous NSAID injection →Control group (placebo)

Peritendinous NSAID injection: Peritendinous NSAID (parecoxib) injection

Control group (placebo): Normal saline mixed with local anesthetics injection

Study summary

This study evaluates whether NSAID peritendinous or ligament injections at acute sprain sites can relieve pain and restore function.

Forty patients will be randomly assigned to either the injection or oral NSAID group. Pain will be assessed subjectively using the Numeric Pain Rating Scale and objectively through pressure pain threshold measurements. Functional outcomes (DASH for the upper limb, FADI for the lower limb) will be evaluated before treatment and at 3 days, 1 week, and 4 weeks post-treatment.

Eligibility

Sex
ALL
Min age
20 Years
Max age
70 Years
Healthy volunteers
No
Inclusion Criteria: * Ultrasonography diagnosed acute tendinitis with inflammation * 20-70 years old Exclusion Criteria: * Cognitive impairment. * Post operation at painful site. * Neuropathic pain or vascularity disease * Unable to receive injection therapy, including a history of syncope during injection. * Allergy history to NSAID * Within 14 days after coronary artery bypass graft, CABG

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Wan Fang Hospital, Taipei Medical University Taipei Taiwan

More Taipei Medical University WanFang Hospital trials in Taiwan

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06834425 on ClinicalTrials.gov ↗ ← All trials in Taiwan